Modified fragment of human growth hormone residues 176–191
PRODUCT PROFILE
AOD-9604
£32.49
AOD-9604 is modified fragment of human growth hormone residues 176–191. Researchers examine it in relation to whether a c-terminal gh fragment can influence lipid metabolism without full gh signalling.
Why it is distinct
A GH-derived metabolic fragment—not an incretin, amylin analogue or GH secretagogue.
- Evidence stageEarly human evidence
- AvailabilityAvailable · 9 in stock
- Batch recordOpen COA
- DispatchConfirmed at checkout
9 in stock
SUGGESTED ADD-ONS
Useful additions, clearly shown.
Suggestions are organised by vial format and catalogue context. They are not combined-use guidance or personal-use advice.
-
Specification review
Bacteriostatic Water
Price range: £4.49 through £8.9910 mL | 3 mLBatch file pendingA laboratory supply with two volume variants, not a peptide or biologically active comparison material.
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Preclinical
BPC-157
£32.99Batch COA availableBPC-157 is mainly discussed around stomach and local tissue-repair models. TB-500 is instead studied for actin, cell movement…
Available · 30 in stockAdd to basket -
Preclinical
TB-500
£32.99Batch COA availableTB-500 is discussed as a fragment-like repair material, while thymosin beta-4 is the full natural protein and BPC-157…
Available · 30 in stockAdd to basket
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
AOD-9604 is modified fragment of human growth hormone residues 176–191. Researchers examine it in relation to whether a c-terminal gh fragment can influence lipid metabolism without full gh signalling.
Research focus+
Researchers study whether it can affect how fat is broken down without producing all the wider effects of full growth hormone. Human results have been limited and it remains experimental.
How the mechanism differs+
Designed to retain proposed lipolytic signalling from a GH fragment while limiting broader growth-promoting activity.
Evidence and limitations+
Small early human studies exist, but efficacy was not established sufficiently for medicine authorisation; much discussion exceeds the evidence.
Testing and batch documentation+
Verified batch documents are available for review.
RESEARCH PROFILE
Understand the distinction.
Researchers study whether it can affect how fat is broken down without producing all the wider effects of full growth hormone. Human results have been limited and it remains experimental.
Designed to retain proposed lipolytic signalling from a GH fragment while limiting broader growth-promoting activity.
A GH-derived metabolic fragment—not an incretin, amylin analogue or GH secretagogue.
Small early human studies exist, but efficacy was not established sufficiently for medicine authorisation; much discussion exceeds the evidence.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Established
Tirzepatide
£79.0010 mgBatch COA availableDual incretin agonism distinguishes it from single-target semaglutide and triple-target retatrutide.
UnavailableAsk about availability -
Phase 2 clinical research
MOTS-c
£35.64Batch COA availableMOTS-c begins inside mitochondria and is studied for cell-wide energy adaptation, rather than directly targeting appetite receptors.
Available · 30 in stockAdd to basket -
Experimental
Retatrutide + Cagrilintide
£59.995 mg + 5 mg | 10 mg + 10 mgBatch file pendingIt combines triple-receptor agonism with a separate amylin pathway, rather than adding another agent acting through the same…
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Phase 3 clinical research
Retatrutide
Price range: £49.99 through £209.9910 mg | 20 mg | 30 mg | 40 mg | 50 mg | 60 mgBatch COA availableIt is the only triple-receptor agonist in this catalogue: GIP, GLP-1 and glucagon.
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page